The possibility of a Senate trial in Biden’s first 100 days in office could be a roadblock for the plan.
Nevertheless, Biden aims to have 100 million COVID-19 vaccine doses administered in his first 100 days in office.
Biden’s plan also earmarks $50 billion for COVID-19 testing and would strengthen the nation’s use of genomic testing to track SARS-CoV-2 mutations.
To date, there have been more than 30,000,000 COVID-19 vaccine doses distributed in the U.S., with roughly one-third of that total receiving the first vaccine dose.
Biden also has vowed to invoke the Defense Production Act to bolster COVID-19 vaccine production.
Overall, the plan would be considerably larger than the December stimulus, which called for $20 billion for vaccine procurement and $12 billion for vaccine distribution and adding to the Strategic National Stockpile. The stimulus also invested $22 billion in COVID-19 testing and tracing.
It took lawmakers seven months to reach that deal.
In related news, Politico has reported that President Trump has asked for a $4 billion reduction in funding for COVID-19 vaccination from the organization GAVI, a public-private partnership dedicated to vaccinating developing nations.